Synapse - Works

Results (676)

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study

Journal Article

Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
Lancet (2024)

Fulltext@MSK | Save

Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology guideline

Guidelines

Bedrosian, I.; Somerfield, M. R.; Achatz, M. I.; Boughey, J. C.; Curigliano, G.; Friedman, S.; Kohlmann, W. K.; Kurian, A. W.; Laronga, C.; Lynce, F.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Impact of reactive changes on multigene testing: Histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores

Journal Article

Grabenstetter, A.; Brogi, E.; Thompson, D. M.; Blinder, V. S.; Norton, L.; Morrow, M.; Robson, M. E.; Wen, H. Y.
Breast Cancer Research and Treatment (2024)

Fulltext@MSK | Save

Cost-effectiveness of adjuvant olaparib for patients with breast cancer and germline BRCA1/2 mutations journal article

Journal Article

Zettler, C. M.; De Silva, D. L.; Blinder, V. S.; Robson, M. E.; Elkin, E. B.
JAMA Network Open (2024)

Fulltext@MSK | Save

Germline pathogenic variants and genetic counseling by ancestry in patients with epithelial ovarian cancer

Journal Article

Sia, T. Y.; Maio, A.; Kemel, Y. M.; Arora, K. S.; Gordhandas, S. B.; Kahn, R. M.; Salo-Mullen, E. E.; Sheehan, M. A.; Tejada, P. R.; Bandlamudi, C.; more...
JCO Precision Oncology (2023)

Fulltext@MSK | Save

Risk of radiation-associated secondary malignancies among patients with breast cancer harboring TP53 germline variants

Meeting Abstract

Cederquist, G.; Boe, L.; Walsh, M. F.; Stadler, Z.; Xu, A. J.; Mueller, B. A.; Roth O'Brien, D. A.; Bernstein, M. B.; Cuaron, J.; Bakhoum, S. F.; more...
International Journal of Radiation Oncology, Biology, Physics (2023)

Fulltext@MSK | Save

Pan-cancer assessment of the impact of intronic variants on cancer development and progression

Meeting Abstract

Safonov, A.; Mehine, M.; Ceyhan-Birsoy, O.; Brown, D.; Bandlamudi, C.; Forbes, A.; Gazzo, A.; Selenica, P.; Shen, R.; Khurana, E.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Aspire to ASCENT: Real-world outcomes from patients with metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan (Saci) in a single academic institution

Meeting Abstract

Walsh, E. M.; Klar, M.; Abuhadra, N.; Robson, M.; Drago, J.
Annals of Oncology (2023)

Fulltext@MSK | Save

Prognostic implications of HER2 gain in patients with HR+/ HER2-breast cancer (BC) and TNBC after neoadjuvant chemotherapy (NAC)

Meeting Abstract

Ferraro, E.; Chew Minmin, S.; Nemirovsky, D.; Chen, Y.; Barrio, A. V.; Modi, S.; Seidman, A.; Wen, H.; Brogi, E.; Robson, M.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Clinical use of PARP inhibitors in BRCA mutant and non-BRCA mutant breast cancer

Journal Article

Lynce, F.; Robson, M.
Cancer Treatment and Research (2023)

Fulltext@MSK | Save